6 enrolling by invitation. 6 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Enrolling by invitation 6 |
| Phase 2 | 2 | Enrolling by invitation 2 |
Follow Arthritis: new trials by email Literature Review of Arthritis trials Research Report on Arthritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis Injection, Etanercept, 25 Mg (Code May Be Used for Medicare When Drug Administered Under the Direct Supervision of A Physician, Not for Use When Drug is Self Administered) - Juvenile Idiopathic Arthritis | Phase 3 | Enrolling by invitation | University of Child Health Sciences and Children's Hospital, Lahore | 60 | 2026-01-27 | 2026-02-04 |
| A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis Sonelokimab - Arthritis, Psoriatic | Phase 3 | Enrolling by invitation | MoonLake Immunotherapeutics AG | 1560 | 2025-11-13 | 2026-09-09 |
| Efficacy Test of Curcuminoid Standardized Turmeric Capsules to Improving Inflammatory Biomarkers in Osteoarthritis Genu Curcuminoid Standardized Turmeric Capsules, Placebo - Osteoarthritis | Phase 2 / Phase 3 | Enrolling by invitation | Gadjah Mada University | 72 | 2025-06-01 | 2025-09-19 |
| Phase III Trial of VDJ001 In Patients With Moderate-to-severe Active Rheumatoid Arthritis Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection - Rheumatoid Arthritis (RA), Anti IL-6R | Phase 3 | Enrolling by invitation | Beijing VDJBio Co., LTD. | 615 | 2025-04-09 | 2025-08-11 |
| Pivotal Clinical Trial to Evaluate the Efficacy and Safety After NPNP-001 Application in Patients with Knee Osteoarthritis. NPNP-001, Conjuran - Knee Osteoarthritis | Phase 3 | Enrolling by invitation | PharmaResearch Co.,Ltd | 260 | 2025-01-08 | 2025-01-20 |
| Orthobiologic Treatment for Knee Osteoarthritis PRP injection, ADSTEM Inj. (Adult human mesenchymal stem cells), Injection - Osteoarthritis Knee | Phase 2 / Phase 3 | Enrolling by invitation | University Hospital of North Norway | 160 | 2024-09-23 | 2026-06-15 |
Osteoarthritis (3) · Osteoarthritis, Knee (2) · Arthritis, Juvenile (1) · Arthritis, Psoriatic (1) · Arthritis, Rheumatoid (1) · Pain (1)
Joint Diseases (6) · Musculoskeletal Diseases (6) · Rheumatic Diseases (5) · Skin and Connective Tissue Diseases (3) · Autoimmune Diseases (2) · Connective Tissue Diseases (2) · Immune System Diseases (2) · Bone Diseases (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Psoriasis (1) · Signs and Symptoms (1) · Skin Diseases (1) · Skin Diseases, Papulosquamous (1)
Injections (2) · Etanercept (1) · Nuclear Receptor Subfamily 4, Group A, Member 2 (1) · Sodium Chloride (1) · sonelokimab (1)
Beijing VDJBio Co., LTD. (1) · Gadjah Mada University (1) · MoonLake Immunotherapeutics AG (1) · PharmaResearch Co.,Ltd (1) · University Hospital of North Norway (1) · University of Child Health Sciences and Children's Hospital, Lahore (1)
China (1) · Indonesia (1) · Norway (1) · Pakistan (1) · South Korea (1) · United States (1)
Faisal Haneef (1)